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Abstract: 
Although the leading cause of death among black men in the United States is coronary artery disease (CAD), 
risk factors have not been well documented in black populations. Therefore, possible racial differences in the 
relation of several characteristics to the extent of CAD were assessed in 4,722 white and 169 black men who 
underwent arteriography. Associations between an occlusion score (ranging from 0 to 300), reflecting the 
severity of CAD, and levels of total and high-density lipoprotein (HDL) cholesterol, triglycerides, cigarette 
smoking, alcohol intake, relative weight, systemic hypertension and diabetes mellitus were examined. Most risk 
factors were significantly related to the extent of CAD in both races, but lipid levels showed stronger 
associations with CAD among blacks: correlations between CAD and total cholesterol were 0.16 (whites) vs 
0.29 (blacks) and associations with HDL cholesterol were -0.22 (whites) vs -0.49 (blacks). In addition, at 
adverse levels of certain risk factors, blacks had more extensive CAD than did whites: mean occlusion scores 
were 148 (whites) and 238 (blacks) at HDL cholesterol levels <30 mg/dl. As assessed by multiple linear 
regression, however, only triglyceride levels were differentially related to CAD between whites (β = 0) and 
blacks (β = 0.47), p <0.01 for racial contrast. These results document the importance of risk factors in black 
men and indicate black/white differences in the relation of triglycerides to CAD. 
 
Article: 
Although blacks in the United States have one of the highest mortality rates due to coronary artery disease 
(CAD) in the world, risk factors among blacks have not been extensively studied.
1,2
 Even higher mortality rates 
among black men, due to a high prevalence of hypertension, may be mitigated by elevated levels of high-
density lipoprotein (HDL) cholesterol.
3
 Levels of total cholesterol, along with the prevalence of diabetes 
mellitus and cigarette smoking, are similar in white men and black men.
4 
 
The Evans County Study, the first prospective study of risk factors in blacks, showed that elevated levels of 
total cholesterol and blood pressure, along with cigarette smoking,
5,6
 were predictive of CAD in black men. A 
subsequent report, however, suggested that black men with low (<170 mg/dl) levels of total cholesterol were 
also at increased risk for the clinical manifestations of CAD.
7
 Follow-up studies of black men in the Multiple 
Risk Factor Intervention Trial
8,9
 showed that levels of total and low-density lipoprotein cholesterol, but not 
HDL cholesterol, were predictive of subsequent clinical disease. Additional longitudinal studies of risk factors 
in blacks are needed, in part, to overcome the small number of events among blacks in Evans County (31 of 
294) and in the Multiple Risk Factor Intervention Trial (16 of 465). 
 
However, the relation of risk factors to anatomically defined CAD can be assessed using data collected during 
arteriography.
10
 Using this approach, Maynard et al
11
 reported that diabetes mellitus, cigarette smoking and total 
cholesterol were associated with increased CAD among 571 blacks. Although the importance of triglyceride 
and HDL cholesterol levels was not assessed in this report, other cross-sectional studies have found that levels 
of HDL cholesterol are not significantly associated with CAD in black Men.
12,13
 
The relation of risk factors to the severity of anatomically defined CAD in whites has been previously 
described.
10,14,15
 The current study, involving 4,722 white and 169 black men, examines possible racial 
differences in the relation of risk factors to CAD. Because previous studies
7,9,12,13
 suggest that the association of 
total (or HDL) cholesterol with CAD may differ between whites and blacks, particular attention is given to lipid 
levels. 
 
METHODS 
Population and disease status: Our study included 4,891 men (3.5% black), ages 24 to 84 years, referred 
for diagnostic coronary arteriography between 1972 and 1986. Prior myocardial infarction was reported by 48% 
of patients and chest pain was present in 74%. Levels of total cholesterol and triglycerides were recorded for all 
patients. 
 
Arteriograms were evaluated, without knowledge of risk factors, by a radiologist and cardiologist experienced 
in their interpretation. Disagreements were resolved by consensus after consultation with a second cardiologist. 
Percent reductions in lumen diameter (0%, 1 to 50%, 51 to 74%, 75 to 89%, 90 to 99% and 100%) due to the 
most severe stenosis in the left main, left anterior descending, circumflex and right coronary arteries were 
incorporated into an occlusion score reflecting the overall severity of CAD. A scale suggested by Rowe et al
16
 
was modified, with a score of 0 representing no observed occlusion and a score of 300 denoting total occlusion 
of the major arteries. 
 
Risk factor information: Medical records and questionnaires were used to obtain data concerning obesity, 
alcohol consumption, smoking, education, recent medication use and histories of hypertension, myocardial 
infarction, angina and diabetes mellitus. The dates of these clinical events were unknown. Patients were ex-
cluded if they reported use of thyroid or cholesterol-lowering medication, or had hypo- or hyperthyroidism. 
These restrictions eliminated 532 patients, leaving 4,891 subjects available for analysis. 
 
Height and weight were used to calculate Quetelet index (kg/m
2
). A 5-point smoking scale, reflecting both 
frequency and duration of smoking (1 = never smoked; 5 = smoked ≥2 packs daily for ≥20 years), was 
calculated. Usual alcohol intake (including beer, wine and mixed drinks) was converted to ounces per week of 
absolute alcohol. Data concerning smoking history and alcohol intake were available for 4,367 (89%) patients. 
Following an overnight fast, blood samples were collected before arteriography. Plasma levels of total 
cholesterol and triglycerides were measured using automated procedures 
17-19
 in a laboratory standardized (and 
monitored) by the Centers for Disease Control. Beginning in 1977, levels of HDL cholesterol have been 
measured in 1,002 white and 32 black men using procedures followed by the Lipid Research Clinics.
19
 The ratio 
of total to HDL cholesterol was used as an estimate of the atherogenicity of each patient's lipoprotein profile. 
 
Statistical analyses: Levels of selected characteristics were first compared between white men and black men 
using t and chi-square tests. Although several distributions were skewed, Wilcoxon tests yielded similar results. 
Following adjustment for age, quintiles of several risk factors were formed and racial comparisons of CAD 
were made within each risk-factor stratum. (These analyses used the same cutpoints in both races.) Analysis of 
covariance, also adjusted for age, was used to compare mean occlusion scores according to diabetes, 
hypertension, smoking status and educational achievement. Associations between risk factors and CAD were 
examined using partial correlations. 
 
Multiple linear regression, including interaction terms (race X risk factor), was used to examine black/ white 
differences in the relation of risk factors to CAD. The statistical significance (at the 0.05 level) of each product 
term was assessed by a backward elimination procedure in a model that included all main effects.
20 
Separate 
models were also fit for each race and regression coefficients were compared between whites and blacks using 
the standard error of their difference (i.e., the square root of the sum of the variances divided by the total sample 
size). Standardized regression coefficients, representing the change in occlusion predicted by a standard 
deviation change in each predictor variable, were used to compare the relative importance of each risk factor. 
 
 
RESULTS 
Mean levels of selected characteristics describing the extent of CAD are listed in Table I. Although the mean 
ages of black men and white men were almost identical, whites had more coronary artery occlusion primarily 
due to the large proportion of black men with minimal CAD (44% of blacks vs 31% of whites did not have 
significant narrowing of any vessel). This racial difference in stenotic disease was most pronounced in the left 
anterior descending artery. Although similar proportions of blacks and whites reported a previous myocardial 
infarction or chest pain, the increased CAD among whites existed irrespective of these characteristics. 
 
The levels of risk factors compared between whites and blacks are listed in Table II. Plasma levels of total and 
HDL cholesterol showed no racial difference, but whites had higher triglyceride levels. Although a greater 
proportion of black men reported a history of diabetes mellitus, the prevalence of hypertension was similar in 
both races. Cumulative smoking histories were also similar, but black men were more likely to currently smoke 
cigarettes than were white men. 
 
Risk factors were then categorized into quintiles. Table III shows that the associations between lipids and CAD 
were stronger in blacks when compared with white men. For example, increases in mean occlusion scores 
associated with triglycerides (quintile 5-quintile l) were 40 (whites) versus 90 (blacks). Although based on 
smaller numbers, the mean occlusion scores in blacks varied by >140 points across quintiles of both HDL and 
total/HDL cholesterol. Similar black/white differences were also seen in age-adjusted correlations between risk 
factors and coronary artery occlusion. Correlations with levels of triglycerides were r = 0.10 (whites) versus 
0.27 (blacks), and 0.25 versus 0.67 for the ratio of total to HDL cholesterol. In contrast to these fairly strong 
associations, alcohol intake showed a U-shaped association with occlusion in blacks. 
 
These racial differences in associations between lipids and CAD existed irrespective of a previous myocardial 
infarction. For example, age-adjusted correlations between triglycerides and CAD were r = 0.12 (whites) versus 
0.33 (blacks) among patients who did not report a previous myocardial infarction (data not shown). Among 
patients who had a myocardial infarction, corresponding correlations with triglycerides were 0.05 and 0.26, 
respectively. Despite small numbers, the ratio of total to HDL cholesterol also remained strongly associated 
with occlusion among blacks in both the nonmyocardial infarction group (r = 0.66) and in patients who had had 
a myocardial infarction (r = 0.67). 
 
Table III also allows black/white differences in occlusion to be examined among patients with similar risk-
factor levels. At favorable levels of lipids and smoking history, blacks had lower occlusion scores than did 
whites. For example, at levels of total cholesterol ≤190 mg/dl (quintile 1), the mean occlusion scores were 112 
(whites) and 81 (blacks). However, at adverse risk-factor levels, the mean occlusion scores were either similar 
between the races (for total cholesterol and smoking history) or were higher among blacks (for triglycerides and 
HDL cholesterol). The 12 black men with HDL cholesterol levels <35 mg/dl (quintiles 1 and 2) had a mean 
occlusion score of 212. 
 
The mean levels of coronary artery occlusion, according to categories of other risk factors, are listed in Table 
IV. Increased occlusion scores were associated with both diabetes and hypertension, but not with smoking 
status (never/past/current). However, the increase in occlusive disease that was associated with diabetes tended 
to be greater in white men, whereas the effect of hypertension was slightly stronger among blacks. Educational 
achievement tended (3 = 0.12) to be related to the extent of CAD only among black men. 
 
To statistically test black/white differences in associations with CAD, race X risk-factor product terms were 
then examined in regression analyses. After controlling for the effects of other risk factors (with the exception 
of HDL cholesterol), the relation of triglyceride levels to CAD differed between white men and black men.  
Although significantly related to CAD in both races, triglycerides showed a stronger association with occlusion 
among blacks (β = 0.25) than among whites (β = 0.03), p = 0.007 for racial contrast. No other risk factor 
showed a. black/white difference in its association with CAD. Although HDL cholesterol was measured in only 
21% of the patients, when this lipoprotein fraction was included as a predictor variable, triglycerides remained 
significantly related to the extent of CAD in blacks (β = 0.47) but not whites (β = 0). HDL cholesterol was 
inversely related to the extent of CAD in both races. 
 
Regression models were then fit separately for each race, with standardized regression coefficients shown in 
Figure 1. A large black/white difference in the relation of triglycerides to CAD was again seen, with standard-
ized regression coefficients of 0.21 (blacks) and 0.05 (whites). A 1-unit standard deviation change in triglyc-
erides was associated with a 24-point change in the occlusion score among blacks, but with only a 7-point 
change among whites. Associations of CAD with cholesterol, age, smoking history and Quetelet index were 
similar in blacks and whites. Although the results were suggestive of racial differences in the relation of alcohol 
intake, diabetes and hypertension to CAD, the contrasts were not statistically significant (p >0.20 for all differ-
ences). 
 
DISCUSSION 
These results indicate that risk factors predictive of clinical manifestations of CAD in whites are associated with 
anatomically defined disease in black men. Age, levels of total and HDL cholesterol, cigarette smoking, 
diabetes mellitus and hypertension were significantly related to the extent of CAD in both races. However, tri-
glyceride levels were more strongly related to CAD among blacks than whites. Although the independent 
relation of triglyceride levels to disease is' controversial,
15,21
 these findings indicate that this association exists 
in black men even after controlling for HDL cholesterol. 
 
CAD is the leading cause of death among black Americans,
1
 but the importance of risk factors has been 
assessed in relatively few studies of black populations. Although cigarette smoking and blood pressure have 
consistently been predictive of clinical disease in black Men,
6,8,22 
the impact of diabetes and alcohol consump-
tion on subsequent disease in blacks has not been examined.
2
 (Diabetes mellitus, however, is associated with in-
creased coronary atherosclerosis in blacks.
23
) In contrast, generalized obesity in whites has often been only 
weakly associated with both clinical disease
24
 and anatomically defined CAD.
10
 In the present study, Quetelet 
index was not associated with the extent of CAD in either race. 
 
However, results of previous studies have been suggestive of black/white differences in the relation of lipids to 
CAD. Although the relation of total cholesterol to CAD was similar between whites and blacks in the 
Coronary Artery Surgery Study,
11
 results from Evans County indicate that mortality from ischemic heart disease 
among blacks is increased at levels of cholesterol <170 mg/dl.
7
 (Low levels of total cholesterol in blacks may 
reflect large decreases in the HDL fraction.) Furthermore, in contrast to the consistent, inverse relation seen in 
whites,
25
 HDL cholesterol levels in black men were not predictive of clinical disease
9
 and have not been 
significantly related to documented CAD.
12,13
 Because of the small number of blacks in several of these studies, 
it has been recommended
26
 that risk factors among blacks be further studied. Although triglyceride levels were 
not predictive of mortality among black men in Evans County, only 10 deaths occurred in the black cohort.
27 
 
The current results show that CAD in black men is independently related to levels of triglycerides (positively) 
and HDL cholesterol (negatively). However, reasons for the stronger association between triglycerides and 
CAD in blacks, as compared with whites, are not clear. In the current study triglyceride levels were higher 
among white men. Furthermore, correlations between HDL cholesterol and triglycerides showed no racial dif-
ference (r = -0.38 vs -0.41) and, although the relation of triglycerides to CAD may be strongest at low levels of 
cholesterol,
28
 blacks and whites had similar levels in the current study. Possibly, the elevated triglyceride levels 
in black men are more strongly related to additional atherogenic characteristics. Sniderman et al
29
 found that 
among hypertriglyceridemics, patients who also have elevated levels of apolipoprotein B have increased CAD. 
 
Several limitations of the present study should also be considered in interpreting the results. The power of these 
analyses to detect racial differences in certain risk-factor associations (e.g., HDL cholesterol) is limited because 
of the relatively small number of black men. In addition, results of coronary arteriography do not always agree 
with histologic findings and observer variation exists in the interpretation of arteriograms. Furthermore, because 
arteriography is performed on symptomatic cases thought to be surgical candidates, patients are not 
representative of the total CAD population. Although it is likely that selection factors for arteriography differ 
between the races, possibly resulting in a biased estimate of the black/white difference in CAD, the increased 
stenotic disease among whites existed irrespective of a history of chest pain or myocardial infarction. 
 
As reported in other arteriography studies,
11,30
 black men had lower levels of triglycerides than did white men, 
but were more likely to currently smoke and to be diabetic. Although these racial differences parallel those 
observed in the general population,
2,4
 racial comparisons of certain risk factors may be biased. For example, as 
opposed to findings from population-based studies, the prevalence of hypertension and levels of HDL cholester-
ol were similar between whites and blacks. Relatively affluent blacks, who are likely overrepresented in arteri-
ography studies, tend to have decreased levels of HDL cholesterol.
31
 However, differences in the relation of risk 
factors to CAD are unlikely to be due to selection factors and similar racial differences were seen irrespective of 
a previous myocardial infarction. Risk factor associations in arteriography studies have generally confirmed the 
findings of population-based studies.
10
 
 
Blacks in the US have one of the highest mortality rates due to CAD in the world' and the characteristics that 
have been established as risk factors in whites are prevalent among blacks. The present findings document that, 
in general, these risk factors are related to CAD in blacks. Although few black/white differences exist, the 
relation of triglyceride levels to CAD, a subject of much controversy,
21 
is stronger among blacks. Although fur-
ther documentation of risk-factor associations is important if persons with moderately elevated cholesterol lev-
els are to be treated,
26
 the current results suggest that triglyceride levels should also be measured when assessing 
the risk of clinical complications of CAD in black men. 
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